Table 3.
Treatment outcomes among patients with TB recorded in TCIS and e-PSS during 2020–2021 in Wuhan, China.
| Treatment outcome* | TCIS (n = 1,021) | E-PSS (n = 976) | P-value |
|---|---|---|---|
| N (%) | N (%) | ||
| Favorable outcome | 940 (92.07) | 903 (92.52) | 0.704 |
| Cured | 428 (41.92) | 375 (38.42) | |
| Treatment completed | 512 (50.15) | 528 (54.10) | |
| Unfavorable outcome | 81 (7.93) | 73 (7.48) | |
| Failure | 1 (0.10) | 2 (0.20) | |
| Died | 19 (1.86) | 27 (2.77) | |
| Lost to follow up | 9 (0.88) | 4 (0.41) | |
| Transferred to RR/MDR-TB | 8 (0.78) | 2 (0.20) | |
| Other | 44 (4.31) | 38 (3.89) |
*
There were 555 cases in TCIS and 169 cases in e-PSS without evaluation recorded.